Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34007011.
- Also identified by DOI 10.1038/s41366-021-00837-y and PMC identifier 8316269.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Obesity is common among people living with HIV (PLWH) and early-stage infection, yet associations with combination antiretroviral (cART) adherence are unclear. Among PLWH initiating cART in Uganda and South Africa, body mass index (BMI) was assessed at cART initiation, and cART adherence was monitored in real-time over 12 months. The association of obesity (BMI ≥ 30 kg/m<sup>2</sup>) with adherence was assessed among nonpregnant participants with CD4 > 350 cells/mm<sup>3</sup> using fractional regression modeling. Among 322 participants, median age was 32 years, 70% were female, and 54% were from Uganda. Prevalence of obesity was 12% in Uganda and 28% in South Africa. Mean overall cART adherence was 83% in Uganda and 66% in South Africa. Participants with obesity had higher adherence than those without obesity: +3.6% (p = 0.44) in Uganda and +11.4% (p = 0.02) in South Africa. Obesity at cART initiation was common and associated with higher adherence, although only significantly in South Africa.
Medical subject headings
- Antiretroviral Therapy, Highly Active
- HIV Infections
- Obesity
- Drug Monitoring